Searchable abstracts of presentations at key conferences in endocrinology

ea0005p261 | Thyroid | BES2003

The epidemiology of thyroid cancer in Scotland, 1960 - 1999

Weir J , Brewster D , Strachan M

Background : The aim of this study was to investigate trends in incidence, mortality and survival for thyroid cancer, in Scotland.Methods : Thyroid cancer registration data (for the period 1960-1997) were obtained from the Scottish Cancer Registry and death registration data (1960-1999) were provided by the General Register Office, Scotland. Trends were examined using rate calculations and relative survival analysis.Results : During the period 1960-1997, the age-standa...

ea0005p196 | Reproduction | BES2003

Clinical features of patients with macroprolactinaemia

Teoh W , Strachan M , Don-Wauchope A , Beckett G , Stoddart M , Seth J

Macroprolactin (MPL) is a complex of prolactin (PRL) and IgG. It is considered to have little bioactivity and may account for a significant proportion of patients with 'idiopathic hyperprolactinaemia'. We determined the prevalence of macroprolactinaemia in patients with hyperprolactinaemia and examined the clinical features. An Immuno-1 system with PEG precipitation was used to identify MPL, with a recovery of <50% taken as indicating significant macroprolactinaemia.In ...

ea0009oc35 | Oral Communication 5: Thyroid | BES2005

Risk of second cancers among people with thyroid cancer - treatment effects or common aetiology?

Sandeep T , Strachan M , Reynolds R , Brewster D , Scelo G , Pukkala E , Hemminki K , Anderson A , Tracey E , Friis S , McBride M , Kee-Seng C , Pompe-Kirn V , Kliewer E , Tonita J , Jonasson J , Martos C , Boffetta P , Brennan P

BackgroundIncreasing incidence of thyroid cancer together with improved prognosis raises a concern regarding development of second primary cancers. Moreover, little is known about the incidence of thyroid cancer as a second primary neoplasm after other cancers.MethodsA cohort of 39002 people (356034.5 person years) with primary thyroid cancer was identified in 13 population-based cancer registries in Europe, ...